A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Dose-response Relationship of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme
Phase of Trial: Phase II
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Follitropin delta (Primary) ; Follitropin beta
- Indications Female infertility
- Focus Therapeutic Use
- Sponsors Ferring Pharmaceuticals
- 20 Oct 2016 Status changed from active, no longer recruiting to completed.
- 09 May 2016 Planned End Date changed from 1 Aug 2016 to 1 Sep 2016.
- 09 Dec 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.